Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.73 - $2.73 $1,971 - $7,371
-2,700 Reduced 6.03%
42,100 $98,000
Q2 2023

Jul 31, 2023

BUY
$2.49 - $20.59 $6,972 - $57,652
2,800 Added 6.67%
44,800 $120,000
Q1 2023

Aug 02, 2023

SELL
$15.95 - $25.18 $44,660 - $70,504
-2,800 Reduced 6.25%
42,000 $783,000
Q1 2023

Apr 27, 2023

SELL
$15.95 - $25.18 $135,575 - $214,030
-8,500 Reduced 16.83%
42,000 $783,000
Q4 2022

Jan 26, 2023

SELL
$13.27 - $17.73 $197,723 - $264,177
-14,900 Reduced 22.78%
50,500 $809,000
Q3 2022

Oct 27, 2022

SELL
$11.4 - $14.6 $12,540 - $16,060
-1,100 Reduced 1.65%
65,400 $850,000
Q2 2022

Jul 25, 2022

SELL
$7.94 - $12.96 $31,760 - $51,840
-4,000 Reduced 5.67%
66,500 $702,000
Q1 2022

Apr 21, 2022

BUY
$12.02 - $16.79 $10,818 - $15,111
900 Added 1.29%
70,500 $847,000
Q4 2021

Jan 24, 2022

SELL
$9.93 - $15.39 $87,384 - $135,432
-8,800 Reduced 11.22%
69,600 $981,000
Q3 2021

Oct 22, 2021

BUY
$10.18 - $26.64 $336,958 - $881,784
33,100 Added 73.07%
78,400 $801,000
Q2 2021

Jul 26, 2021

BUY
$18.57 - $35.68 $68,709 - $132,016
3,700 Added 8.89%
45,300 $1.21 Million
Q1 2021

Apr 23, 2021

BUY
$31.0 - $55.72 $266,600 - $479,192
8,600 Added 26.06%
41,600 $1.44 Million
Q4 2020

Jan 25, 2021

BUY
$37.09 - $48.97 $33,381 - $44,073
900 Added 2.8%
33,000 $1.22 Million
Q3 2020

Dec 14, 2020

BUY
$40.47 - $45.5 $866,058 - $973,700
21,400 Added 200.0%
32,100 $1.32 Million
Q2 2020

Jul 23, 2020

BUY
$32.57 - $42.83 $130,280 - $171,320
4,000 Added 59.7%
10,700 $433,000
Q1 2020

Apr 23, 2020

SELL
$23.3 - $45.96 $53,590 - $105,708
-2,300 Reduced 25.56%
6,700 $232,000
Q4 2019

Jan 24, 2020

SELL
$34.58 - $48.06 $4.23 Million - $5.88 Million
-122,300 Reduced 93.15%
9,000 $386,000
Q3 2019

Oct 21, 2019

SELL
$36.98 - $48.45 $4.35 Million - $5.69 Million
-117,500 Reduced 47.23%
131,300 $4.86 Million
Q2 2019

Jul 25, 2019

BUY
$35.13 - $55.53 $2.85 Million - $4.5 Million
81,000 Added 48.27%
248,800 $11.2 Million
Q1 2019

Apr 19, 2019

SELL
$42.83 - $59.91 $1.28 Million - $1.8 Million
-30,000 Reduced 15.17%
167,800 $9.12 Million
Q4 2018

Jan 23, 2019

BUY
$37.97 - $60.16 $474,625 - $752,000
12,500 Added 6.75%
197,800 $9.15 Million
Q3 2018

Oct 19, 2018

SELL
$56.3 - $67.25 $56,300 - $67,250
-1,000 Reduced 0.54%
185,300 $11.3 Million
Q2 2018

Aug 06, 2018

BUY
$44.9 - $64.95 $62,860 - $90,930
1,400 Added 0.76%
186,300 $11.7 Million
Q1 2018

Apr 20, 2018

BUY
$45.35 - $61.65 $907,000 - $1.23 Million
20,000 Added 12.13%
184,900 $8.54 Million
Q3 2017

Oct 23, 2017

BUY
$33.4 - $53.9 $5.51 Million - $8.89 Million
164,900
164,900 $8.87 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.